• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Hydroxychloroquine is neutral in risk of chronic kidney disease in patients with systemic lupus erythematosus.

作者信息

Wu Chia-Ying, Tan Magdalene, Huang Jing-Yang, Chiou Jeng-Yuan, Wei James Cheng-Chung

机构信息

School of Medicine, Chung Shan Medical University, Taichung, Taiwan.

Department of Medical Research, Chung Shan Medical University Hospital, Taichung City, Taiwan.

出版信息

Ann Rheum Dis. 2022 May;81(5):e75. doi: 10.1136/annrheumdis-2020-217728. Epub 2020 May 20.

DOI:10.1136/annrheumdis-2020-217728
PMID:32434824
Abstract
摘要

相似文献

1
Hydroxychloroquine is neutral in risk of chronic kidney disease in patients with systemic lupus erythematosus.羟氯喹对系统性红斑狼疮患者慢性肾脏病的发生风险呈中性影响。
Ann Rheum Dis. 2022 May;81(5):e75. doi: 10.1136/annrheumdis-2020-217728. Epub 2020 May 20.
2
Response to: 'Hydroxychloroquine is neutral in risk of chronic kidney disease in patients with systemic lupus erythematosus' by Wu .
Ann Rheum Dis. 2022 May;81(5):e76. doi: 10.1136/annrheumdis-2020-217804. Epub 2020 May 20.
3
Bilateral retinal vasculitis presenting as the first manifestation of systemic lupus erythematosus: a case report.双侧视网膜血管炎作为系统性红斑狼疮的首发表现：一例病例报告
J Med Case Rep. 2025 Mar 21;19(1):132. doi: 10.1186/s13256-025-05158-6.
4
Hydroxychloroquine modulates elevated expression of S100 proteins in systemic lupus erythematosus.羟氯喹调节系统性红斑狼疮中 S100 蛋白的异常表达。
Lupus. 2019 Jun;28(7):826-833. doi: 10.1177/0961203319846391. Epub 2019 May 8.
5
Systemic lupus Erythematosus activity and Hydroxychloroquine use before and after end-stage renal disease.系统性红斑狼疮活动度和羟氯喹在终末期肾病前后的使用。
BMC Nephrol. 2020 Oct 28;21(1):450. doi: 10.1186/s12882-020-02083-2.
6
Evolution of chronic kidney disease in patients with systemic lupus erythematosus over a long-period follow-up: a single-center inception cohort study.系统性红斑狼疮患者慢性肾脏病的长期随访演变：一项单中心起始队列研究
Clin Rheumatol. 2014 May;33(5):649-57. doi: 10.1007/s10067-014-2527-0. Epub 2014 Feb 19.
7
Systemic Lupus Erythematosus: A Review.系统性红斑狼疮：综述。
JAMA. 2024 May 7;331(17):1480-1491. doi: 10.1001/jama.2024.2315.
8
Hydroxychloroquine-induced phospholipidosis in a case of SLE: the wolf in zebra clothing.系统性红斑狼疮患者中羟氯喹诱发的磷脂沉积症：披着斑马皮的狼。
Ultrastruct Pathol. 2013 Apr;37(2):146-50. doi: 10.3109/01913123.2012.751950.
9
Systemic lupus erythematosus: nephritis, dilated cardiomyopathy, and extensive cutaneous depigmentation responsive to hydroxychloroquine.系统性红斑狼疮：肾炎、扩张型心肌病及对羟氯喹有反应的广泛皮肤色素脱失。
J Am Acad Dermatol. 1995 Nov;33(5 Pt 1):828-30. doi: 10.1016/0190-9622(95)91842-6.
10
The influence of obesity on hydroxychloroquine blood levels in lupus nephritis patients.肥胖对狼疮肾炎患者羟氯喹血药浓度的影响。
Lupus. 2021 Apr;30(4):554-559. doi: 10.1177/0961203320985214. Epub 2021 Jan 5.

引用本文的文献

1
The Role of Hydroxychloroquine in the Management of Rheumatic Disorders: A Comprehensive Review.羟氯喹在风湿性疾病管理中的作用：一项全面综述。
Basic Clin Pharmacol Toxicol. 2025 Aug;137(2):e70082. doi: 10.1111/bcpt.70082.
2
Hydroxychloroquine: A double‑edged sword (Review).羟氯喹：一把双刃剑（综述）
Mol Med Rep. 2025 Apr;31(4). doi: 10.3892/mmr.2025.13467. Epub 2025 Feb 21.
3
Antimalarials in Lupus Nephritis: How Strong Is the Evidence?狼疮性肾炎中的抗疟药：证据有多确凿？
Kidney360. 2024 Dec 1;5(12):1938-1947. doi: 10.34067/KID.0000000626. Epub 2024 Oct 21.
4
Hydroxychloroquine in nephrology: current status and future directions.羟氯喹在肾脏病学中的应用：现状与未来方向。
J Nephrol. 2023 Nov;36(8):2191-2208. doi: 10.1007/s40620-023-01733-6. Epub 2023 Aug 2.
5
Response to therapy at 6 months predicts long-term renal outcome in lupus nephritis with poor kidney function.治疗 6 个月时的反应可预测肾功能不佳的狼疮性肾炎的长期肾脏结局。
Lupus Sci Med. 2022 Dec;9(1). doi: 10.1136/lupus-2022-000773.
6
Association of hydroxychloroquine and cardiac arrhythmia in patients with systemic lupus erythematosus: A population-based case control study.羟氯喹与系统性红斑狼疮患者心律失常的相关性：一项基于人群的病例对照研究。
PLoS One. 2021 May 20;16(5):e0251918. doi: 10.1371/journal.pone.0251918. eCollection 2021.
7
Hydroxychloroquine Does Not Increase the Risk of Cardiac Arrhythmia in Common Rheumatic Diseases: A Nationwide Population-Based Cohort Study.羟氯喹不会增加常见风湿性疾病中心律失常的风险：一项全国范围内基于人群的队列研究。
Front Immunol. 2021 Apr 2;12:631869. doi: 10.3389/fimmu.2021.631869. eCollection 2021.